Advertisement
BWAY vs ECOR
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BWAY is a Buy and ECOR is a StrongBuy.
BWAY's RSI Oscillator ascends from oversold territory
The RSI Indicator for BWAY moved out of oversold territory on October 13, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 20 similar instances when the indicator left oversold territory. In 19 of the 20 cases the stock moved higher. This puts the odds of a move higher at 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Moving Average Convergence Divergence (MACD) for BWAY just turned positive on October 19, 2026. Looking at past instances where BWAY's MACD turned positive, the stock continued to rise in 38 of 50 cases over the following month. The odds of a continued upward trend are 76%.
Following a +5.16% 3-day Advance, the price is estimated to grow further. Considering data from situations where BWAY advanced for three days, in 221 of 264 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.
BWAY may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 43 of 55 cases where BWAY's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 78%.
The Momentum Indicator moved below the 0 level on October 22, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BWAY as a result. In 83 of 100 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 83%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BWAY declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 77%.
The Aroon Indicator for BWAY entered a downward trend on October 14, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 62 (best 1 - 100 worst), indicating steady price growth. BWAY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 62 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 65 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 66 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock slightly better than average.
The Tickeron Valuation Rating of 86 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.813) is normal, around the industry mean (2.874). P/E Ratio (45.760) is within average values for comparable stocks, (2.324). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.052). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (8.681) is also within normal values, averaging (40.124).
ECOR's RSI Indicator remains in oversold zone for 7 days
The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 15 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
ECOR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 01, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ECOR as a result. In 81 of 97 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 84%.
The Moving Average Convergence Divergence Histogram (MACD) for ECOR turned negative on September 29, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In 42 of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.
ECOR moved below its 50-day moving average on October 08, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for ECOR crossed bearishly below the 50-day moving average on October 13, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 15 of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 83%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ECOR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.
The Aroon Indicator for ECOR entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 20 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: ECOR's P/B Ratio (-23.945) is slightly lower than the industry average of (2.874). P/E Ratio (-4.491) is within average values for comparable stocks, (2.324). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.052). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (2.571) is also within normal values, averaging (40.124).
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 58 (best 1 - 100 worst), indicating steady price growth. ECOR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 66 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ECOR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
BWAY | ECOR | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 65 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 86 Overvalued | 20 Undervalued | |
PROFIT vs RISK RATING 1..100 | 66 | 100 | |
SMR RATING 1..100 | 62 | 100 | |
PRICE GROWTH RATING 1..100 | 62 | 58 | |
P/E GROWTH RATING 1..100 | 65 | 66 | |
SEASONALITY SCORE 1..100 | n/a | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
ECOR's Valuation (20) in the Medical Specialties industry is significantly better than the same rating for BWAY (86). This means that ECOR’s stock grew significantly faster than BWAY’s over the last 12 months.
BWAY's Profit vs Risk Rating (66) in the Medical Specialties industry is somewhat better than the same rating for ECOR (100). This means that BWAY’s stock grew somewhat faster than ECOR’s over the last 12 months.
BWAY's SMR Rating (62) in the Medical Specialties industry is somewhat better than the same rating for ECOR (100). This means that BWAY’s stock grew somewhat faster than ECOR’s over the last 12 months.
ECOR's Price Growth Rating (58) in the Medical Specialties industry is in the same range as BWAY (62). This means that ECOR’s stock grew similarly to BWAY’s over the last 12 months.
BWAY's P/E Growth Rating (65) in the Medical Specialties industry is in the same range as ECOR (66). This means that BWAY’s stock grew similarly to ECOR’s over the last 12 months.
| BWAY | ECOR | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 90% | 1 day ago 90% |
| Stochastic ODDS (%) | 1 day ago 78% | 1 day ago 84% |
| Momentum ODDS (%) | 1 day ago 83% | 1 day ago 84% |
| MACD ODDS (%) | 1 day ago 76% | 1 day ago 90% |
| TrendWeek ODDS (%) | 1 day ago 80% | 1 day ago 83% |
| TrendMonth ODDS (%) | 1 day ago 77% | 1 day ago 83% |
| Advances ODDS (%) | 3 days ago 84% | N/A |
| Declines ODDS (%) | 1 day ago 77% | 2 days ago 84% |
| BollingerBands ODDS (%) | 1 day ago 82% | 1 day ago 78% |
| Aroon ODDS (%) | 1 day ago 69% | 1 day ago 86% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
BWAY’s FA Score shows that 0 FA rating(s) are green while ECOR’s FA Score has 1 green FA rating(s).
- BWAY’s FA Score: 0 green, 5 red.
- ECOR’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
BWAY’s TA Score shows that 5 TA indicator(s) are bullish while ECOR’s TA Score has 4 bullish TA indicator(s).
- BWAY’s TA Score: 5 bullish, 3 bearish.
- ECOR’s TA Score: 4 bullish, 6 bearish.
Price Growth
BWAY (@Medical/Nursing Services) experienced а +4.08% price change this week, while ECOR (@Medical/Nursing Services) price change was -10.37% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -1.62%. For the same industry, the average monthly price growth was -10.72%, and the average quarterly price growth was -10.29%.
Reported Earning Dates
BWAY is expected to report earnings on Nov 10, 2026.
ECOR is expected to report earnings on Nov 04, 2026.
Industries' Descriptions
@Medical/Nursing Services (-1.62% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
Advertisement
BWAY and
Correlation & Price change
A.I.dvisor indicates that over the last year, BWAY has been loosely correlated with DCTH. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if BWAY jumps, then DCTH could also see price increases.
| Ticker / NAME | Correlation To BWAY | 1D Price Change % | ||
|---|---|---|---|---|
| BWAY | 100% | -4.51% | ||
| DCTH - BWAY | 33% Loosely correlated | +0.34% | ||
| ISRG - BWAY | 31% Poorly correlated | +3.67% | ||
| MBOT - BWAY | 30% Poorly correlated | +0.19% | ||
| ITGR - BWAY | 28% Poorly correlated | -0.11% | ||
| PLSE - BWAY | 27% Poorly correlated | +2.67% | ||
More | ||||
ECOR and
Correlation & Price change
A.I.dvisor tells us that ECOR and SENS have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ECOR and SENS's prices will move in lockstep.
| Ticker / NAME | Correlation To ECOR | 1D Price Change % | ||
|---|---|---|---|---|
| ECOR | 100% | +0.82% | ||
| SENS - ECOR | 30% Poorly correlated | -7.15% | ||
| QDEL - ECOR | 29% Poorly correlated | -4.26% | ||
| PFSA - ECOR | 28% Poorly correlated | +20.11% | ||
| AXGN - ECOR | 26% Poorly correlated | +0.55% | ||
| BWAY - ECOR | 26% Poorly correlated | -4.51% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| IGOV | 40.21 | 0.13 | +0.32% |
| iShares International Treasury Bond ETF (IGOV) | |||
| MEMY | 14.83 | N/A | N/A |
| Tuttle Capital Meme Stock Income Blast ETF (MEMY) | |||
| NATO | 36.22 | -0.28 | -0.77% |
| Themes Transatlantic Defense ETF (NATO) | |||
| WQTM | 27.35 | -1.25 | -4.37% |
| WisdomTree Quantum Computing Fund (WQTM) | |||
| SLON | 31.55 | -3.00 | -8.68% |
| ProShares Ultra Solana ETF (SLON) | |||